Prothena Corp Public (PRTA) FCF Margin (2012 - 2026)
Prothena Corp Public (PRTA) posted quarterly FCF Margin of 56.53% for Q1 2026, up 194497.0% year-over-year from N/an in Q1 2025, and up 100.05% quarter-over-quarter from 111009.52% in Q4 2025.
Prothena Corp Public (PRTA) FCF Margin (2012 - 2026) Analysis & Trends
Prothena Corp Public's FCF Margin history runs 15 years deep, the most recent figure standing at 56.53% for Q1 2026.
- In Q1 2026, FCF Margin rose 194497.0% year-over-year to 56.53%; the TTM figure through Mar 2026 stood at 140.55% (down 4587.0% YoY), while the FY2025 annual figure was 1690.6%, down 157936.0% from the prior year.
- FCF Margin for Q1 2026 stood at 56.53%, up from 111009.52% in the prior quarter.
- The five-year high for FCF Margin was 56.53% in Q1 2026, with the low at 146308.0% in Q1 2024.
- The 5-year median for FCF Margin is 2063.09% (2022), against an average of 17456.34%.
- The sharpest annual moves came in 2024 and 2025: FCF Margin sank 14411777 bps in 2024, then surged 14441956 bps in 2025.
- Prothena Corp Public's FCF Margin stood at 10.27% in 2022, then sank by 161942 bps to 16641.46% in 2023, then soared by 86 bps to 2252.24% in 2024, then sank by 4829 bps to 111009.52% in 2025, then surged by 100 bps to 56.53% in 2026.
- Business Quant data shows PRTA's FCF Margin at 56.53% in Q1 2026, 111009.52% in Q4 2025, and 1680.12% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 30.39% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 13.35% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 25.68% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -77,594.17% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 70.82% |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 22.62% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -22.35% |
| 10 | Prothena Corp Public | 458.45 Mn | 170.25 Mn | - | -2,544.65% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -2,544.65% |
| Mar 31, 2026 | 56.53% |
| Dec 31, 2025 | -111,009.52% |
| Sep 30, 2025 | -1,680.12% |
| Jun 30, 2025 | -1,050.36% |
| Mar 31, 2025 | -1,888.44% |
| Dec 31, 2024 | -2,252.24% |
| Sep 30, 2024 | -4,659.28% |
| Jun 30, 2024 | 11.98% |
| Mar 31, 2024 | -146,308.00% |
| Dec 31, 2023 | -16,641.46% |
| Sep 30, 2023 | 10.69% |
| Jun 30, 2023 | -1,137.05% |
| Mar 31, 2023 | -2,190.23% |
| Dec 31, 2022 | -10.27% |
| Sep 30, 2022 | -2,063.09% |
| Jun 30, 2022 | -2,700.00% |
| Mar 31, 2022 | -3,246.92% |
| Dec 31, 2021 | -1,943.43% |
| Sep 30, 2021 | 80.40% |